COLORECTAL CANCER: SINGLE CENTER EXPERI… | Clinical Trial

Key information

Conditions

Colorectal Cancer (Diagnosis) Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Disease Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Pathologic Processes Pathological Conditions, Signs and Symptoms Rectal Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Paolo Sapienza

Roma, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

colorectal cancer

Exclusion criteria

emergency setting

Treatment and study plan

Primary outcomes

survival

Time frame: from enrolment to end of treatment at 5 years

survival
colorectal cancer survival

Time frame: From enrolment to the end of treatment at 5 years follow-up

survival

Sponsors and collaborators

Lead sponsor

University of Roma La Sapienza

Other

Registry information

Acronym: CRC URomLS

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: May 8, 2026
Registry last updated: May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting